- BCL11B Mutations Are Associated with Higher CD8+ T-Cell Percentage and Favorable Clinical Outcomes in Patients with T-Cell Acute Lymphoblastic LeukemiaChen, Cunte; Zhang, Yuping; Zeng, Xiangbo; Zeng, Chengwu; Przybylski, Grzegorz K.; Li, Yangqiu*Clinical Medicine Insights: Oncology , 2023, 17: 11795549231216427.
- Dynamics of Minimal Residual Disease Defines a Novel Risk-Classification and the Role of Allo-HSCT in Adult Ph-Negative B Cell Acute Lymphoblastic LeukemiaZihong, Cai; Tang, Bingqing; Xu, Xiuli; Huang, Zicong; Liu, Qifa; Zhou, Hongsheng64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), New Orleans, LA, 2022-12-10 To 2022-12-13.
- IKZF1deletions Coupled with CD20 Expression Represents a Novel High-Risk Subtype in Adult B-Cell Progenitor Acute Lymphoblastic LeukemiaTang, Bingqing; Wang, Zhixiang; Lin, Dainan; He, Xianjun; Cai, Zihong; Huang, Kangyu; Zhou, Xuan; Lin, Ren; Liu Xiaoli; Xu, Na; Huang, Fen; Sun, Jing; Liu, Qifa; Zhou, Hongsheng63rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Atlanta, GA, 2021-12-11 To 2021-12-14.
会议论文
CRM1/XPO1-FOXO1 Pathway Is Associated with Clinical Outcome and Represents a Promising Target in B-Cell Acute Lymphocytic Leukemia
21阅读
